Prosecution Insights
Last updated: July 17, 2026
Application No. 17/962,576

End-Modified Branched Block Copolymers As Dual-Functional Soil Surfactants and Humectants

Non-Final OA §103§112
Filed
Oct 10, 2022
Priority
Oct 27, 2021 — provisional 63/272,212
Examiner
JONES JR., ROBERT STOCKTON
Art Unit
1762
Tech Center
1700 — Chemical & Materials Engineering
Assignee
MILLIKEN & Company
OA Round
3 (Non-Final)
70%
Grant Probability
Favorable
3-4
OA Rounds
0m
Est. Remaining
93%
With Interview

Examiner Intelligence

Grants 70% — above average
70%
Career Allowance Rate
783 granted / 1120 resolved
+4.9% vs TC avg
Strong +23% interview lift
Without
With
+22.8%
Interview Lift
resolved cases with interview
Typical timeline
2y 5m
Avg Prosecution
6 currently pending
Career history
1129
Total Applications
across all art units

Statute-Specific Performance

§101
0.4%
-39.6% vs TC avg
§103
80.2%
+40.2% vs TC avg
§102
8.9%
-31.1% vs TC avg
§112
5.1%
-34.9% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1120 resolved cases

Office Action

§103 §112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Continued Examination Under 37 CFR 1.114 A request for continued examination under 37 CFR 1.114, including the fee set forth in 37 CFR 1.17(e), was filed in this application after final rejection. Since this application is eligible for continued examination under 37 CFR 1.114, and the fee set forth in 37 CFR 1.17(e) has been timely paid, the finality of the previous Office action has been withdrawn pursuant to 37 CFR 1.114. Applicant's submission filed on May 21, 2026 has been entered. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 1-12 and 26 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Claim 1 recites the limitation "the z end groups" in the final line. There is insufficient antecedent basis for this limitation in the claim. In particular, the variable z in claim 1 is defined as an integer rather than an end group. Claims 2-12 and 26 depend from claim 1 and are therefore similarly indefinite. The claimed formula does include end groups R3. For the purpose of examination on the merits, claim 1 and its dependent claims will be interpreted as requiring from 2 to 4 R3 groups to be hydrophobic end groups. An amendment to this effect would be sufficient to overcome the rejection under 35 U.S.C. 112(b). Claim Rejections - 35 USC § 103 The text of those sections of Title 35, U.S. Code not included in this action can be found in a prior Office action. Claims 1-10 are rejected under 35 U.S.C. 103 as being unpatentable over Zhao et al. (US 2013/0144014; cited in prior Office action). Regarding Claims 1-3 and 5-10, Zhao teaches multi-arm block copolymers comprising a central core molecule, such as a polyol residue, and at least three copolymer. Each copolymer arm comprises an inner hydrophobic polymer segment covalently attached to the central core molecule and an outer hydrophilic segment covalently attached to the hydrophobic polymer segment (Abstract). One example of Zhao’s copolymer is illustrated in Fig. 1, with PEG (i.e. an alkoxylated segment based on ethylene oxide) is the hydrophilic segment: PNG media_image1.png 432 596 media_image1.png Greyscale Preferred polyols used as the central core molecule (corresponding to the claimed R1) include glycerol and pentaerythritol (p. 3-4, [0042]). These read on multi-functional oxygen-containing polyols with 3 (glycerol) or 4 (pentaerythritol OH groups (i.e. oxygen-containing reactive sites). The number of OH groups in these polyols will correspond to the claimed variable z in the resulting copolymer (i.e. z=3 or 4). The hydrophobic polymer segment corresponds to the following portion of the formula recited in Claim 1: PNG media_image2.png 200 400 media_image2.png Greyscale This segment may be a polyalkylene oxide other than PEG, such as polypropylene oxide (PPO) or polybutylene oxide (PBO), with hydrophobic segments having a molecular weight of about 5,000 specifically identified as being useful (p. 4, [0044]). This reads on the indicated segment where R2 is CH3 or CH2CH3 and x is either approximately 86 (PPO) or 69 (PBO), which falls within the claimed range of 1 to 200. Alternatively, the hydrophobic segment can have a molecular weight of as low as 500 with an upper limit of 40,000 (p. 4, [0044]), corresponding to x=7 (PBO, Mw=500) to 689 (PPO, Mw=40,000). This overlaps the claimed range. The hydrophilic polymer segment corresponds to the following portion of the formula recited in Claim 1: PNG media_image3.png 200 400 media_image3.png Greyscale The hydrophilic polymer segment is preferably polyethylene glycol (PEG) hav a preferred molecular weight of about 1,000 to about 20,000 (p. 4, [0047]-[0048]). This reads on the indicated segment where y ranges from about 22 to about 454, which overlaps the claimed range of 1 to 250. The PEG polymer segment may further include one or more capping groups covalently attached at a terminus of the PEG segment distal from the point of attachment to the hydrophobic polymer. The capping group can be a relatively inert group, such as an alkoxy group. Alternatively, the capping group can be a reactive functional group such as a protected carboxylic acid (p. 5, [0062]). When the chemically reactive group is a carboxylic acid, the protecting group may be a t-butyl group (p. 5, [0063]). This reads on the claimed R3 group where R3 is a hydrophobic carbon chain containing 4 carbons. When a multi-functional polyol such as glycerol or pentaerythritol including 3 or 4 OH groups is employed and capping groups are included on all segments, the number of R3 groups will be 3 or 4. This falls within the claimed range of 2 to 4. As indicated above, Zhao teaches ranges which overlap the claimed ranges. It would have been obvious to one of ordinary skill in the art at the time of filing to select values from the portion of the prior art ranges which overlap (and therefore fall within) the claimed ranges, as they are expressly identified by the prior art as being suitable. A prima facie case of obviousness exists where the claimed ranges overlap or lie inside ranges disclosed by the prior art. See MPEP 2144.05(I). Zhao as applied above reads on Claims 1-3 and 5-10. Regarding Claim 4, as indicated above, exemplary hydrophobic segments include PPO having a molecular weight of about 5,000 (p. 4, [0044]). Zhao also describes exemplary PEG segments having a molecular weight of about 5,000 (p. 4, [0048]). When hydrophobic and hydrophilic segments having approximately identical molecular weights are selected, the propylene oxide content will be approximately 50%. Claims 11, 12, and 26 are rejected under 35 U.S.C. 103 as being unpatentable over Zhao as applied to Claim 1 above, further in view of Mayol et al. (Carbohydrate Polymers, 2014, vol. 102, p. 110-116; cited in prior Office action). Regarding Claims 11, 12, and 26, Zhao remains as applied above. Zhao’s copolymer includes hydrophilic and hydrophobic segments and is therefore understood to be amphiphilic. The copolymer is also described as providing a micellar structure. One of the aims of Zhao’s invention is to improve delivery of hydrophobic drugs (p. 1, [0005]). Zhao further suggests incorporation of functional groups such as carboxylic acids at the terminus of the PEG segments (p. 5, [0062]). Zhao does not teach incorporation of octenylsuccinic anhydride (OSA) as claimed. In the same field of endeavor, Mayol teaches modification of a hydrophilic polymer with OSA. The OSA-modified product is able to self-assemble into micelles, load a hydrophobic drug, and release the active molecule (i.e. drug) with controlled kinetics (Abstract). As shown in Fig. 1 (p. 112), the hydrophilic polymer is modified via reaction of OH groups with OSA, and results in incorporation of a terminal carboxylate functional group as well as the pendant octenyl group (i.e. a hydrophobic group). It would have been obvious to one of ordinary skill in the art at the time of filing to select Mayol’s OSA as the terminal functional group of Zhao’s copolymer, as it is shown to impart the desired carboxylate functionality; demonstrates suitability for loading and release of hydrophobic drugs; is shown to be suitable for use in amphiphilic micelle-forming polymers; and would be expected to react with the terminal OH groups of Zhao’s PEG segments through a mechanism similar to that shown in Mayol’s Fig. 1. Modification in this way reads on Claims 11, 12, and 26. Response to Arguments Applicant's arguments filed May 21, 2026 have been fully considered but they are not persuasive. The Applicant argues that Zhao either alone or in combination with Mayol does not teach controlling the degree of end group substitution such that only a limited subset of the available terminal groups is hydrophobically modified. The Applicant’s characterization of the claims is inconsistent with the language of the claims. Claim 1, for example, recites a formula including end groups R3. The number of end groups is dictated by the variable z, which ranges from 3 to 10. The number of end groups which must be hydrophobic ranges from 2 to 4. When z=3 or 4, the total number of R3 groups will be either 3 or 4. In these cases all available functional arms may be modified with hydrophobic end groups and the newly introduced limitation requiring 2 to 4 hydrophobic end groups will be satisfied. The claims do not positively recite that at least one R3 group is H, so partial functionalization is required only when 2 end groups are hydrophobic or when z is an integer of 5 to 10. Zhao as applied above teaches branched copolymers based on multi-functional oxygen-containing polyols with 3 (glycerol) or 4 (pentaerythritol OH groups (i.e. oxygen-containing reactive sites). The number of OH groups in these polyols will correspond to the claimed variable z in the resulting copolymer (i.e. z=3 or 4). Thus, Zhao’s copolymers may be fully functionalized with hydrophobic end groups and still satisfy the amended claims. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to ROBERT S JONES JR whose telephone number is (571)270-7733. The examiner can normally be reached 9 AM - 5 PM Pacific. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Robert Jones can be reached at (571)270-7733. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /ROBERT S JONES JR/ Supervisory Patent Examiner, Art Unit 1762
Read full office action

Prosecution Timeline

Oct 10, 2022
Application Filed
Aug 26, 2025
Non-Final Rejection mailed — §103, §112
Dec 22, 2025
Response Filed
Jan 21, 2026
Final Rejection mailed — §103, §112
May 21, 2026
Request for Continued Examination
May 22, 2026
Response after Non-Final Action
Jul 01, 2026
Non-Final Rejection mailed — §103, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12559616
CURABLE RESIN COMPOSITION, CURED PRODUCT, DIFFRACTIVE OPTICAL ELEMENT, AND MULTILAYER DIFFRACTIVE OPTICAL ELEMENT
4y 0m to grant Granted Feb 24, 2026
Patent 12522756
ADHESIVE COMPOSITION AND METHODS OF FORMING THE SAME
6y 0m to grant Granted Jan 13, 2026
Patent 12516153
THERMOPLASTIC RESIN, METHOD FOR MANUFACTURING SAME, AND OPTICAL LENS
4y 4m to grant Granted Jan 06, 2026
Patent 12365752
FUNCTIONAL OLIGOMERS AND FUNCTIONAL POLYMERS INCLUDING HYDROXYLATED POLYMERS AND CONJUGATES THEREOF AND USES THEREOF
1y 1m to grant Granted Jul 22, 2025
Patent 12359011
ELECTROCHROMIC BLOCK COPOLYMERS AND DEVICES MADE WITH SUCH COPOLYMERS
1y 0m to grant Granted Jul 15, 2025
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
70%
Grant Probability
93%
With Interview (+22.8%)
2y 5m (~0m remaining)
Median Time to Grant
High
PTA Risk
Based on 1120 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month